Results
|
8581.
|
|
|
8582.
|
|
|
8583.
|
|
|
8584.
|
|
|
8585.
|
|
|
8586.
|
|
|
8587.
|
|
|
8588.
|
|
|
8589.
|
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer? [electronic resource] by
- Backes, Floor J
- Richardson, Debra L
- McCann, Georgia A
- Smith, Blair
- Salani, Ritu
- Eisenhauer, Eric L
- Fowler, Jeffrey M
- Copeland, Larry J
- Cohn, David E
- O'Malley, David M
Producer: 20140122
In:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 23
Availability: No items available.
|
|
8590.
|
|
|
8591.
|
|
|
8592.
|
|
|
8593.
|
Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study. [electronic resource] by
- Antón, A
- Ruiz, A
- Plazaola, A
- Calvo, L
- Seguí, M A
- Santaballa, A
- Muñoz, M
- Sánchez, P
- Miguel, A
- Carrasco, E
- Lao, J
- Camps, J
- Alfaro, J
- Antolín, S
- Cámara, M C
Producer: 20110322
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
8594.
|
Combined chemoradiation for head and neck region myxofibrosarcoma of the maxillary sinus. [electronic resource] by
- Cante, Domenico
- Franco, Pierfrancesco
- Sciacero, Piera
- Girelli, Giuseppe Franco
- Casanova Borca, Valeria
- Pasquino, Massimo
- Tofani, Santi
- Bombaci, Sebastiano
- Migliaccio, Fernanda
- Marra, Annamaria
- Numico, Gianmauro
- La Porta, Maria Rosa
- Ricardi, Umberto
Producer: 20130809
In:
Tumori vol. 99
Availability: No items available.
|
|
8595.
|
APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells. [electronic resource] by
- Mohell, N
- Alfredsson, J
- Fransson, Å
- Uustalu, M
- Byström, S
- Gullbo, J
- Hallberg, A
- Bykov, V J N
- Björklund, U
- Wiman, K G
Producer: 20160218
In:
Cell death & disease vol. 6
Availability: No items available.
|
|
8596.
|
|
|
8597.
|
|
|
8598.
|
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. [electronic resource] by
- Garon, Edward B
- Ciuleanu, Tudor-Eliade
- Arrieta, Oscar
- Prabhash, Kumar
- Syrigos, Konstantinos N
- Goksel, Tuncay
- Park, Keunchil
- Gorbunova, Vera
- Kowalyszyn, Ruben Dario
- Pikiel, Joanna
- Czyzewicz, Grzegorz
- Orlov, Sergey V
- Lewanski, Conrad R
- Thomas, Michael
- Bidoli, Paolo
- Dakhil, Shaker
- Gans, Steven
- Kim, Joo-Hang
- Grigorescu, Alexandru
- Karaseva, Nina
- Reck, Martin
- Cappuzzo, Federico
- Alexandris, Ekaterine
- Sashegyi, Andreas
- Yurasov, Sergey
- Pérol, Maurice
Producer: 20140903
In:
Lancet (London, England) vol. 384
Availability: No items available.
|
|
8599.
|
|
|
8600.
|
|